145 related articles for article (PubMed ID: 24303437)
1. Early Detection of Serum Levels of HER-2 in Patients with Head and Neck Squamous Cell Carcinoma.
Khademi B; Khademi B; Ghaderi A; Hosseini SF; Niknejad N
Iran J Otorhinolaryngol; 2013 Jun; 25(72):161-8. PubMed ID: 24303437
[TBL] [Abstract][Full Text] [Related]
2. Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma.
Sanada T; Islam A; Kaminota T; Kirino Y; Tanimoto R; Yoshimitsu H; Yano H; Mizuno Y; Okada M; Mitani S; Ugumori T; Tanaka J; Hato N
Laryngoscope; 2020 May; 130(5):E327-E334. PubMed ID: 31219623
[TBL] [Abstract][Full Text] [Related]
3. Ferritin: A potential serum marker for lymph node metastasis in head and neck squamous cell carcinoma.
Hu Z; Wang L; Han Y; Li F; Zheng A; Xu Y; Wang F; Xiao B; Chen C; Tao Z
Oncol Lett; 2019 Jan; 17(1):314-322. PubMed ID: 30655769
[TBL] [Abstract][Full Text] [Related]
4. Serum CD109 levels reflect the node metastasis status in head and neck squamous cell carcinoma.
Hagiwara S; Sasaki E; Hasegawa Y; Suzuki H; Nishikawa D; Beppu S; Terada H; Sawabe M; Takahashi M; Hanai N
Cancer Med; 2021 Feb; 10(4):1335-1346. PubMed ID: 33565282
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of EGFR as a prognostic and diagnostic marker for head and neck squamous cell carcinoma patients.
Polanska H; Raudenska M; Hudcová K; Gumulec J; Svobodova M; Heger Z; Fojtu M; Binkova H; Horakova Z; Kostrica R; Adam V; Kizek R; Masarik M
Oncol Lett; 2016 Sep; 12(3):2127-2132. PubMed ID: 27602151
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological Parameters and Biomarker Profile in a Cohort of Patients With Head and Neck Squamous Cell Carcinoma (HNSCC).
Hashmi AA; Bukhari U; Aslam M; Joiya RS; Kumar R; Malik UA; Zia S; Khan AR; Saleem M; Irfan M
Cureus; 2023 Jul; 15(7):e41941. PubMed ID: 37588336
[TBL] [Abstract][Full Text] [Related]
8. Serum Level of Matrix Metalloproteinase-9 in Patients with Head and Neck Squamous Cell Carcinoma.
Stanciu AE; Zamfir-Chiru-Anton A; Stanciu MM; Popescu CR; Gheorghe DC
Clin Lab; 2016 Aug; 62(8):1569-1574. PubMed ID: 28164611
[TBL] [Abstract][Full Text] [Related]
9. Arterial spin labeling perfusion-weighted MR imaging: correlation of tumor blood flow with pathological degree of tumor differentiation, clinical stage and nodal metastasis of head and neck squamous cell carcinoma.
Abdel Razek AAK; Nada N
Eur Arch Otorhinolaryngol; 2018 May; 275(5):1301-1307. PubMed ID: 29582174
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Cyclin D1 and Human Epidermal Growth Factor Receptor 2 Neu Protein Expression in Head and Neck Squamous Cell Carcinoma.
Sinha S; Das S; Mohiyuddin SMA
Cureus; 2023 Feb; 15(2):e35526. PubMed ID: 37007344
[TBL] [Abstract][Full Text] [Related]
11. Notch1 regulates invasion and metastasis of head and neck squamous cell carcinoma by inducing EMT through c-Myc.
Inamura N; Kimura T; Wang L; Yanagi H; Tsuda M; Tanino M; Nishihara H; Fukuda S; Tanaka S
Auris Nasus Larynx; 2017 Aug; 44(4):447-457. PubMed ID: 27595504
[TBL] [Abstract][Full Text] [Related]
12. [Biological function and clinical significance of long non-coding RNA
Dong YY; Zheng XW; Mijiti M; Tian R; Guo QB; Wu YY; Gao W; Wen SX
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Mar; 58(3):240-249. PubMed ID: 36878503
[No Abstract] [Full Text] [Related]
13. Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma.
Riedel F; Götte K; Schwalb J; Hörmann K
Anticancer Res; 2000; 20(5A):3045-9. PubMed ID: 11062721
[TBL] [Abstract][Full Text] [Related]
14. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of neutrophil gelatinase-associated lipocalin in head and neck squamous cell carcinoma correlated with tumorigenesis, not with metastasis.
Wang L; Chen C; Li F; Hua Q; Chen S; Xiao B; Dai M; Li M; Zheng A; Yu D; Hu Z; Tao Z
Int J Clin Exp Pathol; 2015; 8(8):8857-68. PubMed ID: 26464627
[TBL] [Abstract][Full Text] [Related]
16. HER2/neu expression in head and neck squamous cell carcinoma patients is not significantly elevated.
Sardari Y; Pardis S; Tadbir AA; Ashraf MJ; Fattahi MJ; Ebrahimi H; Purshahidi S; Khademi B; Hamzavi M
Asian Pac J Cancer Prev; 2012; 13(6):2891-6. PubMed ID: 22938479
[TBL] [Abstract][Full Text] [Related]
17. Tissue and circulating immunoreactive protein for MMP-2 and TIMP-2 in head and neck squamous cell carcinoma--tissue immunoreactivity predicts aggressive clinical course.
Ruokolainen H; Pääkkö P; Turpeenniemi-Hujanen T
Mod Pathol; 2006 Feb; 19(2):208-17. PubMed ID: 16424893
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of HER-2/neu expression on squamous head and neck carcinomas.
Cavalot A; Martone T; Roggero N; Brondino G; Pagano M; Cortesina G
Head Neck; 2007 Jul; 29(7):655-64. PubMed ID: 17315173
[TBL] [Abstract][Full Text] [Related]
19. Serum biomarkers in head and neck squamous cell cancer.
Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Tissue Expression and Salivary Levels of HER2/neu in Patients with Head and Neck Squamous cell Carcinoma.
Pardis S; Sardari Y; Ashraf MJ; Andisheh Tadbir A; Ebrahimi H; Purshahidi S; Khademi B; Fattahi MJ; Hamzavi M
Iran J Otorhinolaryngol; 2012; 24(69):161-70. PubMed ID: 24303404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
